Quipt Announces Execution of LOI To Acquire Leading Respiratory Supplier With Approximately $13 Million in Annualized Revenue and $1.6 Million in Net Income and Provides Outlook for 2022 Calendar End Run-rate of $180-$190 Million With $38-$43 Million in Adjusted EBITDA
